This short report uses data from the 2010 and 2011 National Surveys on Drug Use and Health (NSDUHs), the 2010 Treatment Episode Data Set (TEDS), the 2010 National Survey of Substance Abuse Treatment Services (N-SSATS), and the 2011 Drug Abuse Warning Network (DAWN) to present facts about adolescent substance use...
A Treatment Episode Data Set (TEDS) report that provides a unique national perspective of the characteristics associated with people coming to substance abuse treatment with concurrent benzodiazepine and narcotic pain reliever abuse, using data from 2000-2010.
This report uses 2013 National Survey on Drug Use and Health (NSDUH) to assess the prevalence of substance use and mental disorders among those aged 12 or older, adolescents aged 12 to 17, and adults aged 18 or older and the receipt of treatment/services for behavioral health issues. The 2013...
This short report uses data on drug-related emergency department (ED) visits from the Drug Abuse Warning Network (DAWN) to examine the trends and characteristics of ED visits involving drug-related suicide attempts among ED patients aged 45-64 in 2011. The report discusses the patterns for male and female patients, the drugs...
This short report uses data on drug-related emergency department (ED) visits to examine the involvement of zolpidem in ED visits that are related to overmedication. Zolpidem is a medication used to treat insomnia. Overmedication may occur when a patient takes too much of their own medications (i.e., exceeds the prescribed...
This issue of The CBHSQ Report presents facts about substance use among young adults, including initiation, receipt of treatment, and emergency department visits for substance use \
This report provides methodological information on how to obtain estimates of behavioral health outcomes for populations living on and off tribal lands and provides some initial estimates using NSDUH 2005 to 2014 data.
for example, 12th grade aged dropouts were more likely to be current cigarette users (55.9 vs. 20.2 percent), be alcohol users (41.1 vs. 33.7 percent), engage in binge alcohol use (31.8 vs. 22.1 percent), engage in any illicit drug use (31.4 vs. 18.1 percent), engage in marijuana use (27.5 vs...
This report uses 2015 NSDUH data to explore the reasons for prescription drug misuse in the United States among adults aged 18 or older.
This report shows the estimated number of emergency department visits where the patient was intentionally poisoned or drugged by another person in 2011. The report specifically talks about gender, the types of drugs involved, the role of alcohol, and the outcome of the visits.
This Drug Abuse Warning Network (DAWN) short report shows the estimated number of emergency department visits involving phencyclidine (PCP) between 2005 and 2011. The report specifically talks about age groups, gender and other drugs such as marijuana, cocaine, heroin and pharmaceuticals and trends over time.
This Drug Abuse Warning Network (DAWN) short report looks at the estimated number of emergency room visits for adverse reactions involving involving the prescription sleep qie zolpidem for 2005 through 2010. The report focuses on gender, age groups and other pharmaceuticals such as pain relievers, other anti-anxiety and insomnia medications...
This Drug Abuse Warning Network (DAWN) short report summarizes key findings about drug-related emergency department visits between 2004 and 2011. The report includes data for illicit drugs, alcohol, and prescription and over-the counter medications. For medications, the report looks at misuse and abuse, adverse reactions, and accidental ingestion of drugs...
This Drug Abuse Warning Network (DAWN) short report shows the estimated number of emergency room visits involving attention deficit/hyperactivity disorder stimulant medications between 2005 and 2010. The report shows visits for nonmedical use, adverse reactions, visits involving other pharmaceuticals, illicit drugs or alcohol.
This Drug Abuse Warning Network (DAWN) report shows emergency room visits in 2010 involving synthetic cannabinoid products commonly called \"Spice\" or \"K2\". These drugs are also known as synthetic marijuana,
Visit the SAMHSA Facebook page
Visit SAMHSA on Twitter
Visit the SAMHSA YouTube channel
Visit SAMHSA on LinkedIn
To sign up for updates or to access your subscriber preferences, please enter your contact information.
Language Assistance Available
Have a question about government service? Contact USA.gov